| Quantity: | |
|---|---|
This product contains attenuated Classical Swine Fever Virus Lapinized Strain (CVCC AV1412). Each dose contains no less than 750 Rabbit Infectious Doses (RID).
Spongy loose mass, easily detached from the bottle wall and rapidly soluble after adding a diluent.
For the prevention of classical swine fever. Protective immunity develops 4 days after vaccination. The immune duration lasts 12 months for weaned piglets without maternal antibodies.
Administer via intramuscular or subcutaneous injection. Dilute the vaccine with normal saline to 1 dose per mL according to the dose specified on the vial label, and administer 1.0 mL per pig.
In areas free of classical swine fever epidemics, a single vaccination is sufficient for weaned piglets without maternal antibodies. In areas under epidemic threat, piglets may be vaccinated twice at approximately 21–30 days of age and 65 days of age respectively.
Piglets before weaning may be vaccinated with 4 doses to avoid reduced immune efficacy caused by maternal antibody interference.
10 doses/vial, 20 doses/vial, 50 doses/vial, 100 doses/vial
Store at ≤ -15 °C. Shelf life: 18 months from the date of manufacture.
For use only under veterinary supervision.
High-standard antigen content for strong protection: Adopts classic hog cholera lapinized attenuated strain with antigen content ≥750 rabbit infectious doses per dose. It delivers excellent immunogenicity, stable antibody response and reliable defense against classical swine fever virus.
Rapid immune onset and ultra-long protection cycle: Effective immunity is generated on the 4th day after vaccination. The immune duration lasts up to 12 months for weaned piglets without maternal antibodies, greatly reducing annual vaccination frequency and labor costs.
Multi-scene scientific immunization for full farm prevention:Complete hierarchical immune schemes adapt to regular prevention, epidemic emergency vaccination and maternal antibody interference avoidance. The flexible procedure suits different farm epidemic pressure and piglet ages.
Effectively avoids maternal antibody interference:High-dose advance vaccination for pre-weaning piglets breaks through maternal antibody barriers, eliminates immune blank periods caused by immunosuppression and solidifies piglet defense from the source.
Stable freeze-dried formulation for efficient operation: The loose sponge-like freeze-dried powder dissolves rapidly without caking or residue after dilution, supporting efficient large-scale batch vaccination in pig farms.
A: This is a cell-origin live classical swine fever vaccine, a non-prescription veterinary drug, specially used for the prevention of classical swine fever, serving as the core basic vaccine for pig farms.
Q: What are the inoculation method, dosage and basic immunization procedure?
A: Inject intramuscularly or subcutaneously after dilution with normal saline to 1 dose/ml, 1ml per head for routine vaccination. Single vaccination is enough for weaned piglets without maternal antibodies in non-epidemic areas; double vaccination at 21–30 days and 65 days old is required for farms under epidemic threat.
Q: How to vaccinate pre-weaning piglets? Can it avoid maternal antibody interference?
A: Yes. Pre-weaning piglets can receive high-dose vaccination of 4 doses to break through maternal antibody interference, prevent reduced immune efficacy and establish basic immunity in advance.
Q: What are the immune onset time and overall protection cycle?
A: Effective immunity is generated 4 days after vaccination with ultra-fast onset. The immune protection period lasts up to 12 months for weaned piglets without maternal antibodies, realizing long-term stable prevention and cost saving.
Q: What are the special storage and transportation requirements? How long can it be stored at room temperature temporarily?
A: Transportation requires refrigeration below 8℃. If stored at 8–25℃ after receipt, the vaccine must be used within 10 days to ensure stable vaccine activity.
Q: What is the temperature-based time limit for diluted vaccine use?
A: Use diluted vaccine within 6 hours below 15℃ and within 3 hours at 15–27℃. Exceeding the time limit will reduce viable vaccine activity and cause immune failure.
